This is a preview of subscription content, log in via an institution to check access.
References
Chabner E, Nixon A, Gelman R et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1998; 16: 2045-51.
Boyd J, Sonoda Y, Federici MG et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. Jama 2000; 283: 2260-5.
Verhoog LC, Brekelmans CT, Seynaeve C et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 [see comments]. Lancet 1998; 351: 316-21.
Verhoog LC, Brekelmans CT, Seynaeve C et al. Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 1999; 17: 3396-402.
Hakem R, de la Pompa JL, Sirard C et al. The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 1996; 85: 1009-23.
Gowen LC, Johnson BL, Latour AM et al. BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet. 1996; 12: 191-4.
Sharan SK, Morimatsu M, Albrecht U et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 1997; 386: 804-10.
Pierce LJ, Strawderman M, Narod SA et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations [In Process Citation]. J Clin Oncol 2000; 18: 3360-9.
Ford D, Easton DF, Bishop DT et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994; 343: 692-5.
Schrag D, Kuntz KM, Garber JE, Weeks JC. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations [see comments]. Jama 2000; 283: 617-24.
Couch FJ, DeShano ML, Blackwood MA et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-15.
Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-89.
Berry DA, Parmigiani G, Sanchez J et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history [see comments]. J Natl Cancer Inst 1997; 89: 227-38.
Isaacs C KE, Brogan B, Peshkin BN et al. Acceptance and impact of BRCA1/2 testing in newly diagnosed high risk breast cancer patients. Proceedings American Society Clinical Oncology A149. J Clinical Oncology 2001: 38a.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wong, J., Garber, J. Commentary on Eccles et al.: Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Familial Cancer 1, 73–74 (2001). https://doi.org/10.1023/A:1013844807960
Issue Date:
DOI: https://doi.org/10.1023/A:1013844807960